Immunomedics, Inc. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Immunomedics with three other
pharmaceutical manufacturers in North America:
sales of 3.75 million Canadian Dollars [US$2.82 million]
Pluristem Therapeutics Incorporation.
of which 100%
was Stem Cells Expansion), and
During the year ended June of 2016, sales at
Immunomedics were $3.23 million.
decrease of 42.8%
versus 2015, when the company's sales were $5.65 million.